Skip to main content
Passa alla visualizzazione normale.


Pari opportunità

GIUSEPPE CABIBBO

Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C

  • Authors: Camma,C;Petta,S;Cabibbo,G;Ruggeri,M;Enea,M;Bruno,R;Capursi,V;Gasbarrini,A;Alberti,A;Craxi, A; WEF Study group
  • Publication year: 2013
  • Type: Articolo in rivista (Articolo in rivista)
  • OA Link: http://hdl.handle.net/10447/89386